Please login to the form below

Not currently logged in
Email:
Password:

Sinopharm

This page shows the latest Sinopharm news and features for those working in and with pharma, biotech and healthcare.

Sinovac’s COVID-19 vaccine receives WHO emergency use listing

Sinovac’s COVID-19 vaccine receives WHO emergency use listing

The Sinovac COVID-19 vaccine is the second vaccine developed in China to receive an EUL from the WHO, after Chinese state-owned Sinopharm secured an EUL for its inactivated

Latest news

More from news
Approximately 3 fully matching, plus 8 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
IGNIFI

We’re IGNIFI. An independent creative agency, we help spark and sustain successful brands for some of the biggest names in...

Latest intelligence

Five big changes in the healthcare comms landscape
The world of healthcare has changed very greatly in the five years since The Difference Collective launched. Our agile model and talented team have enabled us to keep pace with...
Early communications in Pharma: How effective pre-approval comms delivers launch success
What communications are required for a successful launch...
Our Top 5 Pharma Picks From Cannes Lions
Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....